• 한국과학교육학회지
• /
• 제28권1호
• /
• pp.67-74
• /
• 2008

본 연구의 목적은 산-염기 적정 실험에서 MBL 방법과 전통 방법에서 실험 소요 시간과 학생-학생 언어적 상호작용을 비교 분석하여 MBL방법이 실험수행과정에 미치는 영향을 알아보는 것이다. MBL 실험 방법은 염산과 수산화나트륨의 중화 반응에서 전도도 센서를 사용하였고, 전통 실험 방법은 전류계를 이용하여 전도도 변화를 측정하였다. 전통 방법의 실험 소요 시간은 MBL의 소요 시간에 비해 1시간 이상 더 길었으며, 이러한 시간의 차이는 대부분 실험 수행 과정에서 나타났다. 두 방법의 학생-학생 언어적 상호작용의 차이도 실험수행 과정에서 크게 나타났고, MBL 방법에서는 전통 방법보다 심층적 대화수와 심층적 대화 비율이 각각 2배 이상 차이를 보였다.

• 약학회지
• /
• 제28권5호
• /
• pp.293-297
• /
• 1984

The pKa' of tranylcypromine was determined by potentiometric titration and ultraviolet spectrophotometric method and found to be 8.08 and 8.15, respectively. The Papp of tranylcypromine between n-heptane and aqueous buffer solution was measured to be 0.90 at pH 7.48 and 4.50 for Pm. The pKa' of tranylcypromine obtained by means of the partition method was 8.13.

• 약학회지
• /
• 제4권1호
• /
• pp.47-49
• /
• 1959

Another application of the new quantitative analytical method of prussic acid by "Microdiffusion analysis" for the determination of prussic acid in human blood was studied. The blood containing potassium cyanide was dropped in outer room of unit, and then N-sulfuric acid was added. The liberated HCN gas was absorbed into nickel sulfate solution of inner room, afterward, absorbed prussic acid was determined with EDTA by residual titration. The result was coincided with the result of Liebig Denigs' method at ordinary temperature.

• 약학회지
• /
• 제13권2_3호
• /
• pp.80-83
• /
• 1969

Acetylsalicylic acid gives a water-insoluble violet complex with $<\alpha>$-Picolin-Cu(II) reagent. The Complex is extractable well with a mixture of $<\alpha>$-Picolin-tetrachloromethane solution. The Complex salt dissolved in the mixed solution shows a maximum absorption at 620 m$<\mu>$. It has a melting point at $171^{\circ}C-$173^{\circ}C and molar ratio of Acetylsalicylic acid: Cu(II): $<\alpha>$-Picolin was estimated as 2:1:2 by continuous variation method and chelate titration method.

• 대한환경공학회지
• /
• 제34권11호
• /
• pp.743-750
• /
• 2012

$ClO_{2(aq)}$ 분석 방법 중 하나인 UV 흡수법은 여러 염소종이 함유된 용액에서는 흡수 파장 겹침 현상으로 분석에 어려움이 있다. 이러한 문제를 극복하고자 UV 파장 분해법을 이용한 다양한 염소종이 함유된 용액의 $ClO_{2(aq)}$ 농도 정량법을 제안하였다. UV 파장 분해법을 이용한 $ClO_{2(aq)}$ 농도 값은 적정법을 이용한 $ClO_{2(aq)}$ 농도 값과 10%내에서 일치하였다. 따라서 다양한 염소 종들이 포함된 시료에서도 제안된 UV 파장 분해법을 적용한다면 $ClO_{2(aq)}$의 선택적 분석이 가능하다는 것을 알 수 있었다.

• Communications for Statistical Applications and Methods
• /
• 제16권1호
• /
• pp.51-65
• /
• 2009

제 1상 임상시험은 사람을 대상으로 처음 실시되므로 약물 투여의 안전성과 정확성이 신중히 고려되어야 한다. 따라서 제 1상 임상시험에서는 적은 수의 피험자를 통해 최대허용용량(maximum tolerated dose)을 정확하게 찾아야 한다. 제 1상 임상시험에서 최대허용용량을 결정하는 방법에는 표준방법(standard method), 연속재평가방법(continual reassessment method) 그리고 가속적정계획(accelerated titration designs) 방법이 있다. 본 연구에서는 동일한 모형에서 세 방법을 동시에 고려하여 최대허용용량의 안전성과 정확성을 살펴보았다. 또한 세 방법에 대해 최대허용용량에서 기대독성확률을 구하여 비교하였다. 그리고 ATD와 CRM의 단점을 보완한 수정된 ATD와 수정된 CRM을 포함하여 여러 방법들을 동일한 모형에서 동시에 그 성능을 비교하였다.

• 분석과학
• /
• 제31권4호
• /
• pp.143-148
• /
• 2018

Currently, the Korean Pharmacopoeia (KP XI) recommends HPLC and potentiometric titration (which is less specific than HPLC) for the determination of triflusal content in capsules and raw materials, respectively. Additionally, the British Pharmacopoeia (BP 2017) and European Pharmacopoeia (EP 8.0), which include a monograph for triflusal in raw materials only, describe a titration method for the assay. The latest version of the United States Pharmacopoeia (USP 39) and Japanese Pharmacopoeia (JP 17) still have not published monographs for triflusal and its preparations. To improve the specificity and efficacy of the assay, we present an HPLC method to determine triflusal content in both raw materials and capsules. The proposed method was validated in accordance with the requirements of the International Conference on Harmonization. A good linear relationship was achieved for triflusal in the range of $200-1250{\mu}g/mL$ with a coefficient of determination of approximately 0.9996. The relative standard deviations (RSDs) of inter- and intraday precision were 0.73-1.12 % and 0.34-0.51 %, respectively. The recovery percentage of triflusal was in the range of 98.80-101.31 %. Because its system suitability, intermediate precision, and robustness were satisfactory, this method could be suitable for determining triflusal content in raw materials and capsules.

• 한국결정성장학회지
• /
• 제21권6호
• /
• pp.274-279
• /
• 2011

연소 반응기를 이용하여 고분자 물질에 함유된 할로겐 원소인 브롬과 염소를 정량하기 위한 조건을 연구하였다. 염소농도 측정의 경우, Mohr법이나 전위차 적정법을 이용한 경우가 산-염기 적정법을 이용한 경우보다 분석 데이터 간 편차가 낮게 나타났다. 또한, 연소 반응기에서 단계별로 포집한 용액에 대한 염소와 브롬 측정 결과, 두 원소 모두 증류수를 흡수액으로 사용할 때, 0.3 M NaOH 수용액을 사용할 때보다 더 높은 회수율을 보였으며, 흡수액/세척액에서의 농도가 가스상의 형태로 배출되는 농도에 비해 높은 것으로 나타났다. 한편, 브롬 함량을 측정할 때, 연소 반응기를 이용한 경우가 XRF나 연소-이온크로마토그래피를 이용한 경우에 비해 농도가 상대적으로 낮게 평가되는 것으로 나타났다.

• 분석과학
• /
• 제31권3호
• /
• pp.107-111
• /
• 2018

Currently, ultraviolet-visible spectrophotometry and titration methods are used for assay tests of tramadol hydrochloride injection and raw material in the Korean Pharmacopoeia XI (KP XI). Titration has also been used in the British Pharmacopoeia (BP 2013) for the assay test of tramadol hydrochloride, and the HPLC assay for tramadol hydrochloride raw material has been used in the United States Pharmacopeia (USP 39). In this study, we developed an alternative HPLC assay method for tramadol hydrochloride injection that is up to date and specific, and employs the same method as tramadol hydrochloride capsules. Validation of the HPLC method was conducted to determine linearity, precision, accuracy, system suitability, and robustness. The linearity of the calibration curves in the desired concentration range was good ($r^2$ > 0.9999). RSDs of intra-day precision obtained were 0.05-0.08 % and inter-day precision obtained were 0.08-0.19 %. Accuracy was obtained with recoveries in the range of 98.16 % and 100.90 %. As a result of the system's suitability, the RSD of both retention time and the peak area obtained were 0.07 %. The values of the plate number and tailing factor of tramadol hydrochloride obtained were 7076 and 1.16, respectively. Because of the intermediate precision and robustness of the developed assay, it is expected to become a valuable tool for revising the Korean Pharmacopoeia (KP XI).

• 대한치과마취과학회지
• /
• 제2권1호
• /
• pp.1-6
• /
• 2002

The usage of nitrous oxide is increased for the anxious patient to dental treatment. There are two methods to induce the sedation during dental treatment. One is sedation with drugs the other no need of drugs. We discussed here about sedation with drugs. The methods of drug administration are oral, intramuscular, intravenous, inhalation. The method of oral administration of drugs are convenient to patient and doctor but poor controllability. Intramuscular method is a parenteral technique that maintains several advantages over the enteral technique. However its pales in comparison to other parenteral technique. Intravenous method represents most effective method of ensuring predictable and adequate sedation in all patients. But it has inability to reverse the action of drugs after they have been injected except some drugs (e.g., narcotics and benzodiazepine). A variety of gaseous agents may be administered by inhalation to produce sedation. In dental practice, the inhalation administration of gas means use of nitrous oxide. There are many advantages of nitrous oxide administration. First, very short latent period and rapid onset of drug action which lead to possible titration of drug concentration. With nitrous oxide, clinical effects may become noticeable as quickly as 15 to 30 seconds after inhalation. Recovery from inhalation sedation is also quite rapid. In out patient dental practice rapid recovery is very important because it permit to discharge the patient without escort and the patient return to their ordinary life without limit. To success the conscious sedation with nitrous oxide, the administrator should be keep the mind that always titration of nitrous oxide concentration during induction and treatment. Careful observation need during treatment to prevent oversedation because the adequate nitrous oxide concentration to patients changed by environmental stress. Always begins with 100% oxygen and ends with 100% oxygen to prevent diffusion hypoxia which rare in clinical practice.